190 related articles for article (PubMed ID: 17157218)
1. Tryptophan catabolism generates autoimmune-preventive regulatory T cells.
Fallarino F; Grohmann U; You S; McGrath BC; Cavener DR; Vacca C; Orabona C; Bianchi R; Belladonna ML; Volpi C; Fioretti MC; Puccetti P
Transpl Immunol; 2006 Dec; 17(1):58-60. PubMed ID: 17157218
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.
Brenk M; Scheler M; Koch S; Neumann J; Takikawa O; Häcker G; Bieber T; von Bubnoff D
J Immunol; 2009 Jul; 183(1):145-54. PubMed ID: 19535644
[TBL] [Abstract][Full Text] [Related]
3. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells.
Fallarino F; Grohmann U; You S; McGrath BC; Cavener DR; Vacca C; Orabona C; Bianchi R; Belladonna ML; Volpi C; Santamaria P; Fioretti MC; Puccetti P
J Immunol; 2006 Jun; 176(11):6752-61. PubMed ID: 16709834
[TBL] [Abstract][Full Text] [Related]
4. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
[TBL] [Abstract][Full Text] [Related]
6. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.
Puccetti P; Fallarino F
Blood Cells Mol Dis; 2008; 40(1):101-5. PubMed ID: 17881253
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
9. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
11. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
13. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
[TBL] [Abstract][Full Text] [Related]
14. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
[TBL] [Abstract][Full Text] [Related]
15. Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B.
Feunou P; Vanwetswinkel S; Gaudray F; Goldman M; Matthys P; Braun MY
J Immunol; 2007 Jul; 179(2):910-7. PubMed ID: 17617582
[TBL] [Abstract][Full Text] [Related]
16. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 control over Foxp3+ regulatory T cell function.
Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
[TBL] [Abstract][Full Text] [Related]
18. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.
Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP
Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381
[TBL] [Abstract][Full Text] [Related]
20. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation.
Puccetti P; Grohmann U
Nat Rev Immunol; 2007 Oct; 7(10):817-23. PubMed ID: 17767193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
